M. Bogic, N. Savic, Ž. Jovičić, Vesna Spiric-Tomic, Aleksandra Popadic-Peric, S. Rašković, S. Arandjelović, Jasminka Sojic-Rajcic, Miodrag Čolić
{"title":"CLINICAL SIGNIFICANCE OF MEASUREMENT OF INTERLEUKIN 4 AND INTERLEUKIN 5 SERUM CONCENTRATIONS IN BRONCHIAL ASTHMA","authors":"M. Bogic, N. Savic, Ž. Jovičić, Vesna Spiric-Tomic, Aleksandra Popadic-Peric, S. Rašković, S. Arandjelović, Jasminka Sojic-Rajcic, Miodrag Čolić","doi":"10.2298/JMH0401051B","DOIUrl":null,"url":null,"abstract":"Summary: Cytokines IL-4 and IL-5 participate in the chronic inflammation process in the atopic airway diseases. Our study is aimed at determining correlation between IL-4 and IL-5 serum concentrations and severity of the disease in patients with bronchial asthma. The total of 65 patients with asthma is classified into three groups: 1. patients with mild, 2. moderate and 3. severe asthma. The control group comprised 10 healthy individuals. Measurement of IL-4 and IL-5 serum concentrations was performed according to ELISA method. Minimal detectable concentrations of IL-4 and IL-5 were 0.27 pg/mL and 4 pg/mL, respectively. IL-4 (Z = 2.245, p = 0.025) and IL-5 (Z = 2.139, p = 0.032) serum concentrations are significantly lower in healthy individuals in comparison to the individuals with asthma. Comparison of the study results between the groups (mild, moderate and severe asthma) evidenced that IL-4 serum concentrations in the group with moderate (Z = 2.604, p = 0.009) and severe asthma (Z= 2.658, p = 0.008) were statistically significantly higher in comparison to the group with mild asthma. IL-5 serum concentrations in the group with moderate (Z = 3.910, p = 0.000) and severe asthma (Z = 4.037, p = 0.000) were statistically significantly higher in comparison to the group with mild asthma. Further studies on the role of IL-4 and IL-5 in the process of chronic inflammation in asthma are needed.","PeriodicalId":287983,"journal":{"name":"Jugoslovenska Medicinska Biohemija-yugoslav Medical Biochemistry","volume":"06 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"1900-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Jugoslovenska Medicinska Biohemija-yugoslav Medical Biochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2298/JMH0401051B","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 6
Abstract
Summary: Cytokines IL-4 and IL-5 participate in the chronic inflammation process in the atopic airway diseases. Our study is aimed at determining correlation between IL-4 and IL-5 serum concentrations and severity of the disease in patients with bronchial asthma. The total of 65 patients with asthma is classified into three groups: 1. patients with mild, 2. moderate and 3. severe asthma. The control group comprised 10 healthy individuals. Measurement of IL-4 and IL-5 serum concentrations was performed according to ELISA method. Minimal detectable concentrations of IL-4 and IL-5 were 0.27 pg/mL and 4 pg/mL, respectively. IL-4 (Z = 2.245, p = 0.025) and IL-5 (Z = 2.139, p = 0.032) serum concentrations are significantly lower in healthy individuals in comparison to the individuals with asthma. Comparison of the study results between the groups (mild, moderate and severe asthma) evidenced that IL-4 serum concentrations in the group with moderate (Z = 2.604, p = 0.009) and severe asthma (Z= 2.658, p = 0.008) were statistically significantly higher in comparison to the group with mild asthma. IL-5 serum concentrations in the group with moderate (Z = 3.910, p = 0.000) and severe asthma (Z = 4.037, p = 0.000) were statistically significantly higher in comparison to the group with mild asthma. Further studies on the role of IL-4 and IL-5 in the process of chronic inflammation in asthma are needed.
摘要:细胞因子IL-4和IL-5参与了特应性气道疾病的慢性炎症过程。我们的研究旨在确定支气管哮喘患者血清IL-4和IL-5浓度与病情严重程度的相关性。将65例哮喘患者分为三组:1.哮喘患者;轻度患者,2例。中度和3。严重的哮喘。对照组由10名健康个体组成。ELISA法测定血清IL-4、IL-5浓度。IL-4和IL-5的最低检测浓度分别为0.27 pg/mL和4 pg/mL。健康人群血清IL-4 (Z = 2.245, p = 0.025)和IL-5 (Z = 2.139, p = 0.032)浓度显著低于哮喘患者。轻、中、重度哮喘组之间的研究结果比较表明,中度哮喘组(Z= 2.604, p = 0.009)和重度哮喘组(Z= 2.658, p = 0.008)血清IL-4浓度均显著高于轻度哮喘组。中度哮喘组(Z = 3.910, p = 0.000)和重度哮喘组(Z = 4.037, p = 0.000)血清IL-5浓度均显著高于轻度哮喘组。IL-4和IL-5在哮喘慢性炎症过程中的作用有待进一步研究。